{
    "clinical_study": {
        "@rank": "65434", 
        "acronym": "Vent-Hyp", 
        "arm_group": [
            {
                "arm_group_label": "Volume controlled ventilation", 
                "arm_group_type": "Active Comparator", 
                "description": "Volume controlled ventilation: tidal volume of 7 mL/kg ideal body weight, frequency of 12 cycles/minute, I/E ratio of 1:2, no positive end expiratory pressure. Ventilatory frequency is changed if necessary to maintain end-expiratory pressure of CO2 between 35 and 40 mmHg."
            }, 
            {
                "arm_group_label": "Pressure-controlled ventilation", 
                "arm_group_type": "Experimental", 
                "description": "initial pressure of 15 cm H2O, frequency of 12 cycles/minute, I/E ratio of 1:2, no positive end expiratory pressure. Pressure is modified to maintain a tidal volume of 7 mL/kg of ideal body weight and frequency ventilation is modified to maintain end-expiratory pressure of CO2 between 35 and 40 mmHg"
            }
        ], 
        "brief_summary": {
            "textblock": "The risk of bleeding is important during transsphenoidal surgery. This study aims to find if\n      the ventilation mode, controlled pressure and controlled volume, modifies the risk of\n      bleeding."
        }, 
        "brief_title": "Mode of Ventilation and Bleeding During Transsphenoidal Surgery", 
        "completion_date": {
            "#text": "October 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Surgery", 
        "condition_browse": {
            "mesh_term": [
                "Hemorrhage", 
                "Pituitary Neoplasms", 
                "Blood Loss, Surgical"
            ]
        }, 
        "detailed_description": {
            "textblock": "The risk of bleeding is important during transsphenoidal surgery. This study aims to find if\n      the ventilation mode, controlled pressure and controlled volume, modifies the risk of\n      bleeding.\n\n        -  group Volume controlled ventilation: tidal volume of 7 mL/kg ideal body weight,\n           frequency of 12 cycles/minute, I/E ratio of 1:2, no positive end expiratory pressure.\n           Ventilatory frequency is changed if necessary to maintain end-expiratory pressure of\n           CO2 between 35 and 40 mmHg.\n\n        -  group Pressure-controlled ventilation: initial pressure of 15 cm H2O, frequency of 12\n           cycles/minute, I/E ratio of 1:2, no positive end expiratory pressure. Pressure is\n           modified to maintain a tidal volume of 7 mL/kg of ideal body weight and frequency\n           ventilation is modified to maintain end-expiratory pressure of CO2 between 35 and 40\n           mmHg.\n\n        -  In both groups, the fraction of inspired oxygen is 50%. A recruitment maneuver is\n           performed if the blood oxygen saturation became less than 92%."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Aged > 18 years\n\n          -  Patients scheduled for transsphenoidal surgery for pituitary adenomas\n\n        Exclusion Criteria:\n\n          -  Pregnancy\n\n          -  Obesity (BMI> 35)\n\n          -  Known respiratory disease\n\n          -  Redo surgery\n\n          -  Preoperative problem with hemostasis (antiplatelet or anticoagulant treatment;\n             constitutional disorder)."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "100", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "June 29, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01891838", 
            "org_study_id": "2012/15"
        }, 
        "intervention": [
            {
                "arm_group_label": "Volume controlled ventilation", 
                "intervention_name": "Volume controlled ventilation", 
                "intervention_type": "Procedure"
            }, 
            {
                "arm_group_label": "Pressure-controlled ventilation", 
                "intervention_name": "Pressure-controlled ventilation", 
                "intervention_type": "Procedure"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "surgery", 
            "transsphenoidal surgery", 
            "pituitary adenoma", 
            "mechanical ventilation", 
            "bleeding"
        ], 
        "lastchanged_date": "January 7, 2014", 
        "location": {
            "contact": {
                "email": "m.fischler@hopital-foch.org", 
                "last_name": "Marc Fischler, MD", 
                "phone": "46252442", 
                "phone_ext": "00331"
            }, 
            "facility": {
                "address": {
                    "city": "Suresnes", 
                    "country": "France", 
                    "zip": "92150"
                }, 
                "name": "Hopital Foch"
            }, 
            "investigator": {
                "last_name": "Morgan Le Guen, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "France"
        }, 
        "number_of_arms": "2", 
        "official_title": "Transsphenoidal Surgery for Pituitary Adenomas: Influence of the Ventilation Mode on Intraoperative Bleeding", 
        "overall_contact": {
            "email": "m.fischler@hopital-foch.org", 
            "last_name": "Marc Fischler, MD", 
            "phone": "46252442", 
            "phone_ext": "00331"
        }, 
        "overall_official": {
            "affiliation": "H\u00f4pital Foch", 
            "last_name": "Morgan Le Guen, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "France: Agence Nationale de S\u00e9curit\u00e9 du M\u00e9dicament et des produits de sant\u00e9", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "June 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "intraoperative bleeding is estimated by the operator (always the same) as  minimal (1), low (3), with no significant change in the conduct of the surgical procedure (5) with significant change in the conduct of surgical procedure (7). Intermediate  levels are used to rate the levels of intermediate severity.", 
            "measure": "intraoperative bleeding", 
            "safety_issue": "No", 
            "time_frame": "1 hour postoperatively"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01891838"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "mean ventilatory plateau pressure during surgery", 
                "measure": "generated plateau pressures", 
                "safety_issue": "No", 
                "time_frame": "one hour after surgery"
            }, 
            {
                "description": "time spent with the predefined objectives of minute ventilation", 
                "measure": "realisation of predefined objectives of minute ventilation", 
                "safety_issue": "No", 
                "time_frame": "one hour after surgery"
            }, 
            {
                "description": "number of changes of ventilation mode", 
                "measure": "changes of ventilation mode", 
                "safety_issue": "No", 
                "time_frame": "one hour after surgery"
            }, 
            {
                "description": "number of episodes of arterial desaturation (SpO2 <92%) and lower arterial saturation during surgery", 
                "measure": "arterial desaturation", 
                "safety_issue": "No", 
                "time_frame": "one hour after surgery"
            }, 
            {
                "description": "number of recruitment maneuver", 
                "measure": "recruitment maneuver", 
                "safety_issue": "No", 
                "time_frame": "one hour after surgery"
            }, 
            {
                "description": "duration from surgical incision to end of the surgical procedure", 
                "measure": "duration of the surgical procedure", 
                "safety_issue": "No", 
                "time_frame": "one hour after surgery"
            }, 
            {
                "description": "return to a low level of the abnormal endocrin abnormalities", 
                "measure": "endocrine healing", 
                "safety_issue": "No", 
                "time_frame": "three months after surgery"
            }
        ], 
        "source": "Hopital Foch", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Hopital Foch", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "June 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Caregiver), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "January 2014"
    }
}